Page 25 - August 2022_Fulldraftforflipbook_revised

CUA guideline: LUTS/BPH

39. Kaplan SA, He W, Koltun WD, et al. Solifenacin plus tamsulosin combination treatment in men with 60. Kordan Y, Canda AE, Koseoglu E, et al. Robotic-assisted simple prostatectomy: A systematic review. J Clin
lower urinary tract symptoms and bladder outlet obstruction: A randomized controlled trial. Eur Urol Med 2020;9:1798. https://doi.org/10.3390/jcm9061798
2013;63:158-65. https://doi.org/10.1016/j.eururo.2012.07.003 61. Scarcella S, Castellani D, Gauhar V, et al. Robotic-assisted vs. open simple prostatectomy: Results
40. Drake MJ, Chapple C, Sokol R, et al. Long-term safety and efficacy of single-tablet combinations of from a systematic review and meta-analysis of comparative studies. Invsti Clin Urol 2021;62:631-40.
solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower https://doi.org/10.4111/icu.20210297
urinary tract symptoms: Results from the NEPTUNE Study and NEPTUNE II open-label extension. Eur Urol 62. Herrmann TR. Enucleation is enucleation is enucleation is enucleation. World J Urol 2016;34:1353-5.
2015;67:262-70. https://doi.org/10.1016/j.eururo.2014.07.013 https://doi.org/10.1007/s00345-016-1922-3
41. Ichihara K, Masumori N, Fukuta F, et al. A randomized controlled study of the efficacy of tamsulosin 63. Chen CH, Chung CH, Chu HC, et al. Surgical outcome of anatomical endoscopic enucleation of the pros-
monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic tate: A systemic review and meta-analysis. Andrologia 2020;52:e13612. https://doi.org/10.1111/
obstruction. J Urol 2015;193:921-6. https://doi.org/10.1016/j.juro.2014.09.091 and.13612
42. Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved 64. El Tayeb MM, Jacob JM, Bhojani N, et al. Holmium laser enucleation of the prostate in patients requiring
lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, random- anticoagulation. J Endourol 2016;30:805-9. https://doi.org/10.1089/end.2016.0070
ized, parallel, placebo-controlled clinical trial. Eur Urol 2012;61:917-25. https://doi.org/10.1016/j. 65. Rivera M, Krambeck A, Lingeman J. Holmium laser enucleation of the prostate in patients requiring
eururo.2012.01.013 anticoagulation. Curr Urol Rep 2017;18:77. https://doi.org/10.1007/s11934-017-0746-z
43. Gacci M, Corona G, Salvi M, et al. A systematic review and meta-analysis on the use of phosphodiesterase 66. Romero-Otero J, García-González L, García-Gómez B, et al. Factors influencing intraoperative blood
5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign loss in patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic
prostatic hyperplasia. Eur Urol 2012;61:994-1003. https://doi.org/10.1016/j.eururo.2012.02.033 hyperplasia: A large, multicenter analysis. Urology 2019;132:177-82. https://doi.org/10.1016/j.
44. Weiss JP, Herschorn S, Albei CD, et al. Efficacy and safety of low-dose desmopressin orally disintegrating urology.2019.06.024
tablet in men with nocturia: Results of a multicenter, randomized, double-blind, placebo-controlled, parallel 67. Ibrahim A, Alharbi M, Elhilali MM, et al. 18 years of holmium laser enucleation of the prostate: A single-
group study. J Urol 2013;190:965-72. https://doi.org/10.1016/j.juro.2012.12.112 center experience. J Urol 2019;202:795-800. https://doi.org/10.1097/JU.0000000000000280
45. Habib FK Wyllie MG. Not all brands are created equal: A comparison of selected components 68. Gilling PJ, Wilson LC, King CJ, et al. Long-term results of a randomized trial comparing holmium laser
of different brands of Serenoa repens extract. Prostate Cancer Prostatic Dis 2004;7:195-200. enucleation of the prostate and transurethral resection of the prostate: Results at 7 years. BJU Int
https://doi.org/10.1038/sj.pcan.4500746 2012;109:408-11. https://doi.org/10.1111/j.1464-410X.2011.10359.x
46. Barry MJ, Meleth S, Kreder KH, et al. Effect of increasing doses of saw palmetto on lower urinary tract 69. Zhu L, Chen S, Yang S, et al. Electrosurgical enucleation vs. bipolar transurethral resection for prostates
symptoms: A randomized trial. JAMA 2011;306:1344-51. https://doi.org/10.1001/jama.2011.1364 larger than 70 ml: A prospective, randomized trial with 5-year followup. J Urol 2013;189:1427-31.
47. Tacklind J, Macdonald R, Rutks I, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database https://doi.org/10.1016/j.juro.2012.10.117
Syst Rev 2012;12:Cd001423. https://doi.org/10.1002/14651858.CD001423.pub3 70. Elshal AM, Soltan M, El-Tabey NA, et al. Randomized trial of bipolar resection vs. holmium laser enucleation
48. Wilt T, Ishani A, Mac Donald R, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database vs. Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction:
Syst Rev 2002;1:Cd001044. https://doi.org/10.1002/14651858.CD001423 3-year outcomes. BJU Int 2020;126:731-8. https://doi.org/10.1111/bju.15161
49. Cornu JN, Ahyai S, Bachmann AJ, et al. A systematic review and meta-analysis of functional outcomes 71. Świniarski PP, Stępień S, Dudzic W, et al. Thulium laser enucleation of the prostate (TmLEP) vs. transure-
and complications following transurethral procedures for lower urinary tract symptoms resulting from thral resection of the prostate (TURP): Evaluation of early results. Cent European J Urol 2012;65:130-4.
benign prostatic obstruction: An update. Eur Urol 2015;67:1066-96. https://doi.org/10.1016/j. https://doi.org/10.5173/ceju.2012.03.art6
eururo.2014.06.017 72. Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): Long-term results, reoperation
50. Reich O, Gratzke C, Backmann A, et al. Morbidity, mortality, and early outcome of transurethral resection rate, and possible impact of the learning curve. Eur Urol 2007;52:1465-72. https://doi.org/10.1016/j.
of the prostate: A prospective, multicenter evaluation of 10 654 patients. J Urol 2008;180:246-9. eururo.2007.04.074
https://doi.org/10.1016/j.juro.2008.03.058 73. Thomas JA, Tubaro A, Barber N, et al. A multicenter, randomized, non-inferiority trial comparing GreenLight-
51. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment
transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. of benign prostatic obstruction: Two-year outcomes of the GOLIATH study. Eur Urol 2016;69:94-102.
Eur Urol 2010;58:384-97. https://doi.org/10.1016/j.eururo.2010.06.005 https://doi.org/10.1016/j.eururo.2015.07.054
52. Mamoulakis C, Sofras F, de la Rosette J, et al. Bipolar vs. monopolar transurethral resection of the prostate 74. Ajib K, Mansoura M, Zanaty M, et al. Photoselective vaporization of the prostate with the 180-W XPS-
for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes. Can Urol Assoc J
2014;1:CD009629. https://doi.org/10.1002/14651858.CD009629.pub3 2018;12:E318-24. https://doi.org/10.5489/cuaj.4895
53. Geavlete B, Georgescu D, Multescu R, et al. Bipolar plasma vaporization vs. monopolar and bipolar TURP: 75. Bachmann A, Tubaro A, Barber N, et al. 180‐W XPS GreenLight laser vaporization vs. transurethral
A prospective, randomized, long-term comparison. Urology 2011;78:930-5. https://doi.org/10.1016/j. resection of the prostate for the treatment of benign prostatic obstruction: 6‐month safety and effi-
urology.2011.03.072 cacy results of a European multicenter, randomized trial — the GOLIATH study. Eur Urol 2014;65:931.
54. Muslumanoglu AY, Yuruk E, Binbay M, et al. Transurethral resection of prostate with plasmaki- https://doi.org/10.1016/j.eururo.2013.10.040
netic energy: 100 months results of a prospective, randomized trial. BJU Int 2012;110:546-9. 76. Bachmann A, Schurch L, Ruszat R, et al. Photoselective vaporization (PVP) vs. transurethral resection of
https://doi.org/10.1111/j.1464-410X.2011.10770.x the prostate (TURP): A prospective bicenter study of perioperative morbidity and early functional outcome.
55. Varkarakis I, Kyriakakis Z, Delis A, et al. Long-term results of open transvesical prostatectomy from Eur Urol 2005;48:965-71. https://doi.org/10.1016/j.eururo.2005.07.001
a contemporary series of patients. Urology 2004;64:306-10. https://doi.org/10.1016/j.urol- 77. Rajih E, Tholomier C, Hueber PA, et al. Evaluation of surgical outcomes with Photoselective GreenLight XPS
ogy.2004.03.033 laser vaporization of the prostate in high medical risk men with benign prostatic enlargement: A multicenter
56. Lin, Y, Wu X, Xu A, et al. Transurethral enucleation of the prostate vs. transvesical open prostatectomy for study. J Endourol 2017;31:686-93. https://doi.org/10.1089/end.2016.0782
large benign prostatic hyperplasia: A systematic review and meta-analysis of randomized controlled trials. 78. Nguyen DD, Sadri I, Law K, et al. Impact of the presence of a median lobe on functional outcomes of
World J Urol 2016;34:1207-19. https://doi.org/10.1007/s00345-015-1735-9 greenlight photovaporization of the prostate (PVP): An analysis of the Global Greenlight Group (GGG)
57. Naspro R, Gomez Sancha F, Manica M, et al. From “gold standard” resection to reproducible “future Database. World J Urol 2021;39:3881-9. https://doi.org/10.1007/s00345-020-03529-w
standard” endoscopic enucleation of the prostate: What we know about anatomical enucleation. Minerva 79. Lee DJ, Rieken M, Halpern J et al. Laser vaporization of the prostate with the 180‐W XPS‐Greenlight laser
Urol Nefrol 2017;69:446-58. https://doi.org/10.23736/S0393-2249.17.02834-X in patients with ongoing platelet aggregation inhibition and oral anticoagulation. Urology 2016;91:167.
58. Nestler S, Bach T, Herrmann T, et al. Surgical treatment of large volume prostates: A matched pair https://doi.org/10.1016/j.urology.2016.01.021
analysis comparing the open, endoscopic (ThuVEP) and robotic approach. World J Urol 2019;37:1927-31. 80. Meskawi M, Hueber PA, Valdivieso R, et al. Complications and functional outcomes of high-risk patient
https://doi.org/10.1007/s00345-018-2585-z with cardiovascular disease on antithrombotic medication treated with the 532 nm laser photo-
59. Autorino R, Zarger H, Mariano MB, et al. Perioperative outcomes of robotic and laparoscopic vaporization Greenlight XPS-180 W for benign prostate hyperplasia. World J Urol 2019;37:1671-8.
simple prostatectomy: A European-American multi-institutional analysis. Eur Urol 2015;68:86-94. https://doi.org/10.1007/s00345-018-2560-8
https://doi.org/10.1016/j.eururo.2014.11.044

CUAJ • August 2022 • Volume 16, Issue 8 255